These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 9607563
1. Type V collagen is an epithelial cell cycle inhibitor that is induced by and mimics the effects of transforming growth factor beta1. Parekh TV, Wang XW, Makri-Werzen DM, Greenspan DS, Newman MJ. Cell Growth Differ; 1998 May; 9(5):423-33. PubMed ID: 9607563 [Abstract] [Full Text] [Related]
2. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV. Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653 [Abstract] [Full Text] [Related]
3. Novel Cdk inhibitors restore TGF-beta sensitivity in cdk4 overexpressing epithelial cells. Soni R, Fretz H, Muller L, Schoepfer J, Chaudhuri B. Biochem Biophys Res Commun; 2000 Jun 16; 272(3):794-800. PubMed ID: 10860833 [Abstract] [Full Text] [Related]
4. TGF-beta1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression. Ko TC, Yu W, Sakai T, Sheng H, Shao J, Beauchamp RD, Thompson EA. Oncogene; 1998 Jul 02; 16(26):3445-54. PubMed ID: 9692552 [Abstract] [Full Text] [Related]
5. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition. Zhang F, Taipale M, Heiskanen A, Laiho M. Oncogene; 2001 Sep 13; 20(41):5888-96. PubMed ID: 11593394 [Abstract] [Full Text] [Related]
6. The bioactivity of transforming growth factor-beta1 can be regulated via binding to dermal collagens in mink lung epithelial cells. Shibuya H, Okamoto O, Fujiwara S. J Dermatol Sci; 2006 Mar 13; 41(3):187-95. PubMed ID: 16337361 [Abstract] [Full Text] [Related]
7. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912 [Abstract] [Full Text] [Related]
8. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt. Ju EM, Choi KC, Hong SH, Lee CH, Kim BC, Kim SJ, Kim IH, Park SH. Biochem Biophys Res Commun; 2005 Mar 25; 328(4):1170-81. PubMed ID: 15708000 [Abstract] [Full Text] [Related]
9. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells. Hu X, Zhang X, Zhong Q, Fisher AB, Bryington M, Zuckerman KS. Oncogene; 2001 Oct 18; 20(47):6840-50. PubMed ID: 11687963 [Abstract] [Full Text] [Related]
10. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Satterwhite DJ, White RL, Matsunami N, Neufeld KL. Cancer Res; 2000 Dec 15; 60(24):6989-94. PubMed ID: 11156401 [Abstract] [Full Text] [Related]
11. Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity. Tsubari M, Taipale J, Tiihonen E, Keski-Oja J, Laiho M. Mol Cell Biol; 1999 May 15; 19(5):3654-63. PubMed ID: 10207089 [Abstract] [Full Text] [Related]
12. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells. Satterwhite DJ, Aakre ME, Gorska AE, Moses HL. Cell Growth Differ; 1994 Aug 15; 5(8):789-99. PubMed ID: 7986745 [Abstract] [Full Text] [Related]
13. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Ohmori T, Yang JL, Price JO, Arteaga CL. Exp Cell Res; 1998 Dec 15; 245(2):350-9. PubMed ID: 9851876 [Abstract] [Full Text] [Related]
14. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Iavarone A, Massagué J. Nature; 1997 May 22; 387(6631):417-22. PubMed ID: 9163429 [Abstract] [Full Text] [Related]
15. Differential activity of TGF-beta2 on the expression of p27Kip1 and Cdk4 in actively cycling and contact inhibited rabbit corneal endothelial cells. Kim TY, Kim WI, Smith RE, Kay EP. Mol Vis; 2001 Nov 20; 7():261-70. PubMed ID: 11723444 [Abstract] [Full Text] [Related]
16. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1. Boehm JR, Kutz SM, Sage EH, Staiano-Coico L, Higgins PJ. J Cell Physiol; 1999 Oct 20; 181(1):96-106. PubMed ID: 10457357 [Abstract] [Full Text] [Related]
17. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Ando K, Griffin JD. Oncogene; 1995 Feb 16; 10(4):751-5. PubMed ID: 7862452 [Abstract] [Full Text] [Related]
18. Transforming growth factor beta down-regulation of CKShs1 transcripts in growth-inhibited epithelial cells. Simon KE, Cha HH, Firestone GL. Cell Growth Differ; 1995 Oct 16; 6(10):1261-9. PubMed ID: 8845303 [Abstract] [Full Text] [Related]
19. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y, Kyprianou N. Cell Growth Differ; 1998 Feb 16; 9(2):185-93. PubMed ID: 9486855 [Abstract] [Full Text] [Related]
20. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. Arvanitakis L, Yaseen N, Sharma S. J Immunol; 1995 Aug 01; 155(3):1047-56. PubMed ID: 7636179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]